Fortitude Family Office’s Polaryx Therapeutics Inc PLYX Stock Holding History

Fortitude Family Office’s Portfolio PLYX Stock Details PLYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$503	Buy	+189	New	+$742	﹤0.01%	1978

Fortitude Family Office's PLYX Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Polaryx Therapeutics Inc (PLYX) in Q2 2026: 189 shares worth $503. The stake represents ﹤0.01% of the portfolio and ranks #1978 among its holdings.

1 fund tracked by Wall St. Rank holds PLYX as of Q2 2026.

Fortitude Family Office held 189 shares of Polaryx Therapeutics Inc worth $503 as of Q2 2026.
Polaryx Therapeutics Inc was a new Fortitude Family Office position in Q2 2026.
Polaryx Therapeutics Inc made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1978 holding.
1 fund tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.